Evotec
Hamburg · Founded 1993
About Evotec
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.
Company Facts
- Founded: 1993
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $746.7M
- Funding stage: IPO
- Last round: Grant (May 2025)
- Ticker: fra:EVT
- Website: evotec.com
- Phone: + 49 (0)40 56081-222
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/evotec-82451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.